119 related articles for article (PubMed ID: 16098148)
1. SEI family of nuclear factors regulates p53-dependent transcriptional activation.
Watanabe-Fukunaga R; Iida S; Shimizu Y; Nagata S; Fukunaga R
Genes Cells; 2005 Aug; 10(8):851-60. PubMed ID: 16098148
[TBL] [Abstract][Full Text] [Related]
2. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation.
Kong HJ; Yu HJ; Hong S; Park MJ; Choi YH; An WG; Lee JW; Cheong J
Mol Cancer Res; 2003 Nov; 1(13):948-58. PubMed ID: 14638867
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.
Huang SM; Schönthal AH; Stallcup MR
Oncogene; 2001 Apr; 20(17):2134-43. PubMed ID: 11360197
[TBL] [Abstract][Full Text] [Related]
4. Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1.
Chou WY; Ho CL; Tseng ML; Liu ST; Yen LC; Huang SM
Int J Biochem Cell Biol; 2008; 40(9):1826-34. PubMed ID: 18299245
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
6. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
7. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
[TBL] [Abstract][Full Text] [Related]
8. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.
Nagashima M; Shiseki M; Pedeux RM; Okamura S; Kitahama-Shiseki M; Miura K; Yokota J; Harris CC
Oncogene; 2003 Jan; 22(3):343-50. PubMed ID: 12545155
[TBL] [Abstract][Full Text] [Related]
9. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
Li J; Melvin WS; Tsai MD; Muscarella P
Biochemistry; 2004 Apr; 43(14):4394-9. PubMed ID: 15065884
[TBL] [Abstract][Full Text] [Related]
10. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.
Li Q; Wang X; Wu X; Rui Y; Liu W; Wang J; Wang X; Liou YC; Ye Z; Lin SC
Cancer Res; 2007 Jan; 67(1):66-74. PubMed ID: 17210684
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16.
Johnstone RW; Wei W; Greenway A; Trapani JA
Oncogene; 2000 Dec; 19(52):6033-42. PubMed ID: 11146555
[TBL] [Abstract][Full Text] [Related]
12. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.
Maehara K; Yamakoshi K; Ohtani N; Kubo Y; Takahashi A; Arase S; Jones N; Hara E
J Cell Biol; 2005 Feb; 168(4):553-60. PubMed ID: 15716376
[TBL] [Abstract][Full Text] [Related]
13. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
14. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
16. deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes.
King KE; Ponnamperuma RM; Yamashita T; Tokino T; Lee LA; Young MF; Weinberg WC
Oncogene; 2003 Jun; 22(23):3635-44. PubMed ID: 12789272
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
Messner DJ; Romeo C; Boynton A; Rossie S
J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
[TBL] [Abstract][Full Text] [Related]
18. p205, a potential tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation.
Asefa B; Dermott JM; Kaldis P; Stefanisko K; Garfinkel DJ; Keller JR
FEBS Lett; 2006 Feb; 580(5):1205-14. PubMed ID: 16458891
[TBL] [Abstract][Full Text] [Related]
19. TOE1 interacts with p53 to modulate its transactivation potential.
Sperandio S; Tardito S; Surzycki A; Latterich M; de Belle I
FEBS Lett; 2009 Jul; 583(13):2165-70. PubMed ID: 19508870
[TBL] [Abstract][Full Text] [Related]
20. Heat shock transcription factor (Hsf)-4b recruits Brg1 during the G1 phase of the cell cycle and regulates the expression of heat shock proteins.
Tu N; Hu Y; Mivechi NF
J Cell Biochem; 2006 Aug; 98(6):1528-42. PubMed ID: 16552721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]